Use of statins in patients with chronic kidney disease.
Atorvastatin is usually preferred.
#statinsHD #ckdHD #atorvastatinHD #rosuvastatinHD #ezetimibeHD
Louis shares an MRCP UK explainer on statins in CKD: atorvastatin needs no renal dose adjustment (under 2% renal excretion), while rosuvastatin is 30% renally excreted, needs dose reduction at low eGFR and can cause reversible proteinuria at high doses. KDIGO advises a statin with or without ezetimibe in CKD stages 3-5 not on dialysis.
Use of statins in patients with chronic kidney disease.
Atorvastatin is usually preferred.
#statinsHD #ckdHD #atorvastatinHD #rosuvastatinHD #ezetimibeHD
Atorvastatin vs Rosuvastatin in CKD
Core Concept
Statins in CKD are used for CV risk reduction.
Renal benefits are modest, not primary endpoints.Atorvastatin is generally preferred in moderate–advanced CKD due to:
- Less renal clearance (safe in low eGFR)
- No dose adjustment
- Lower incidence of statin-associated proteinuria
- Some evidence of reduced proteinuria + slower eGFR decline
Rosuvastatin is very potent but requires dose reduction in CKD and high doses may cause proteinuria/hematuria.
Atorvastatin
- Hepatic clearance
- <2% renal excretion
- No dose modification for CKD stages 1–5 (non-dialysis)
Rosuvastatin
- 30% renal excretion
- Requires dose reduction in eGFR <30
- Maximum recommended dose often ≤10 mg/day in severe CKD
- High doses associated with tubular proteinuria (reversible)
Renal Effects of statins
Atorvastatin
- Shown to reduce proteinuria modestly
- May slow eGFR decline
- No significant renal toxicity reports
Rosuvastatin
- Dose-dependent proteinuria + microscopic hematuria
- Mechanism: proximal tubular dysfunction
- Usually reversible with dose reduction or cessation
Guideline-Based (KDIGO)
KDIGO Recommendations:
- Use statin ± ezetimibe in CKD stages 3–5 (not on dialysis)
- Avoid high-dose rosuvastatin in advanced CKD
- Atorvastatin commonly preferred because of pharmacokinetics
Which Statin to Start in CKD?
Preferred First-Line in CKD (Moderate–Advanced):Atorvastatin (10–40 mg/day)
Why?
- Safe in low eGFR
- No dose limits
- Less proteinuria risk
- Good LDL reduction
When to Use Rosuvastatin
- Need stronger LDL lowering
- Patient has early CKD (Stage 1–2)
- Start low dose (5–10 mg) if eGFR <30
Exam clue: Severe CKD + high ASCVD risk → Atorvastatin preferred to avoid rosuvastatin-induced proteinuria.